BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32151462)

  • 1. Incident hepatitis B virus infection and immunisation uptake in Australian prison inmates.
    Li H; Cameron B; Douglas D; Stapleton S; Cheguelman G; Butler T; Luciani F; Lloyd AR
    Vaccine; 2020 Apr; 38(16):3255-3260. PubMed ID: 32151462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
    Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
    Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
    Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
    BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?
    Winter RJ; Dietze PM; Gouillou M; Hellard ME; Robinson P; Aitken CK
    J Gastroenterol Hepatol; 2013 Feb; 28(2):314-22. PubMed ID: 23190264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread of bloodborne viruses among Australian prison entrants.
    Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
    BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities.
    Haussig JM; Nielsen S; Gassowski M; Bremer V; Marcus U; Wenz B; Bannert N; Bock CT; Zimmermann R;
    Int J Infect Dis; 2018 Jan; 66():5-13. PubMed ID: 29097248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
    Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
    Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.
    Stone J; Martin NK; Hickman M; Hutchinson SJ; Aspinall E; Taylor A; Munro A; Dunleavy K; Peters E; Bramley P; Hayes PC; Goldberg DJ; Vickerman P
    Addiction; 2017 Jul; 112(7):1302-1314. PubMed ID: 28257600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
    Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
    Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
    Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
    BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of hepatitis C incidence in Australian prisoners.
    Luciani F; Bretaña NA; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR;
    Addiction; 2014 Oct; 109(10):1695-706. PubMed ID: 24916002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
    Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care.
    Papaluca T; McDonald L; Craigie A; Gibson A; Desmond P; Wong D; Winter R; Scott N; Howell J; Doyle J; Pedrana A; Lloyd A; Stoove M; Hellard M; Iser D; Thompson A
    J Hepatol; 2019 May; 70(5):839-846. PubMed ID: 30654067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.
    Macalino GE; Vlahov D; Sanford-Colby S; Patel S; Sabin K; Salas C; Rich JD
    Am J Public Health; 2004 Jul; 94(7):1218-23. PubMed ID: 15226146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, prevalence and risk factors for hepatitis C in Danish prisons.
    Søholm J; Holm DK; Mössner B; Madsen LW; Hansen JF; Weis N; Sauer AP; Awad T; Christensen PB
    PLoS One; 2019; 14(7):e0220297. PubMed ID: 31348813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
    Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
    J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk for acute hepatitis C infection during imprisonment in Australia.
    Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson W; Kaldor J; Lloyd A; Haber P
    Eur J Epidemiol; 2010 Feb; 25(2):143-8. PubMed ID: 20084429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
    Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
    Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.